University of Oulu

Izzi, V., Lakkala, J., Devarajan, R., Savolainen, E.-R., Koistinen, P., Heljasvaara, R. and Pihlajaniemi, T. (2018), Vanin 1 (VNN1) levels predict poor outcome in acute myeloid leukemia. Am J Hematol, 93: E4–E7. doi:10.1002/ajh.24925

Vanin 1 (VNN1) levels predict poor outcome in acute myeloid leukemia

Saved in:
Author: Izzi, Valerio1; Lakkala, Juho1; Devarajan, Raman1;
Organizations: 1Centre of Excellence in Cell-Extracellular Matrix Research and Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland
2Nordlab Oulu and Institute of Diagnostics, Department of Clinical Chemistry, Oulu University Hospital, University of Oulu, Oulu, Finland
3Medical Research Center Oulu, Institute of Clinical Medicine, Oulu University Hospital, University of Oulu, Oulu, Finland
4Centre for Cancer Biomarkers (CCBIO), Department of Biomedicine, University of Bergen, N-5009 Bergen, Norway
Format: article
Version: accepted version
Access: embargoed
Persistent link: http://urn.fi/urn:nbn:fi-fe2017121355797
Language: English
Published: John Wiley & Sons, 2018
Publish Date: 2018-10-23
Series: American journal of hematology
ISSN: 0361-8609
ISSN-E: 1096-8652
ISSN-L: 0361-8609
Volume: 93
Issue: 1
Pages: E4 - E7
DOI: 10.1002/ajh.24925
OADOI: https://oadoi.org/10.1002/ajh.24925
Type of Publication: A1 Journal article – refereed
Field of Science: 1182 Biochemistry, cell and molecular biology
Subjects:
Funding: This work was supported by the Centre of Excellence Grant 2012-2017 of the Academy of Finland (284605), the Sigrid Jusélius Foundation, the Finnish Cancer Foundation and the University of Oulu Graduate School.
Academy of Finland Grant Number: 284605
Detailed Information: 284605 (Academy of Finland Funding decision)
Copyright information: © 2017 Wiley Periodicals, Inc. This is the peer reviewed version of the following article: Izzi, V., Lakkala, J., Devarajan, R., Savolainen, E.-R., Koistinen, P., Heljasvaara, R. and Pihlajaniemi, T. (2018), Vanin 1 (VNN1) levels predict poor outcome in acute myeloid leukemia. Am J Hematol, 93: E4–E7. doi:10.1002/ajh.24925, which has been published in final form at https://doi.org/10.1002/ajh.24925. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving